Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$699K Buy
5,774
+109
+2% +$12.6K 0.62% 37
2025
Q4
$601K Buy
5,665
+396
+8% +$37.2K 0.44% 44
2025
Q3
$447K Sell
5,269
-1,786
-25% -$147K 0.35% 56
2025
Q2
$564K Buy
7,055
+170
+2% +$13.5K 0.47% 47
2025
Q1
$623K Sell
6,885
-200
-3% -$18.7K 0.53% 42
2024
Q4
$710K Sell
7,085
-143
-2% -$14.7K 0.45% 38
2024
Q3
$826K Sell
7,228
-380
-5% -$45.1K 0.32% 59
2024
Q2
$948K Buy
7,608
+1,583
+26% +$204K 0.57% 35
2024
Q1
$800K Sell
6,025
-188
-3% -$23.2K 0.5% 39
2023
Q4
$677K Sell
6,213
-1,556
-20% -$162K 0.43% 43
2023
Q3
$800K Buy
7,769
+2,620
+51% +$282K 0.37% 47
2023
Q2
$594K Sell
5,149
-123
-2% -$14K 0.34% 46
2023
Q1
$561K Sell
5,272
-340
-6% -$36.7K 0.31% 49
2022
Q4
$623K Buy
5,612
+1,509
+37% +$154K 0.35% 50
2022
Q3
$354K Sell
4,103
-42
-1% -$3.75K 0.22% 77
2022
Q2
$378K Buy
4,145
+1,185
+40% +$105K 0.23% 70
2022
Q1
$243K Buy
2,960
+515
+21% +$40.6K 0.2% 84
2021
Q4
$187K Sell
2,445
-1,845
-43% -$147K 0.12% 107
2021
Q3
$323K Buy
4,290
+1,713
+66% +$130K 0.18% 81
2021
Q2
$205K Buy
+2,577
New +$192K 0.16% 86

Other funds holding MRK

Eagle Bay Advisors's MRK Position: Q1 2026 in Review

Eagle Bay Advisors increased its Merck (MRK) stake by 1.9% in Q1 2026, buying an estimated $12.6K and bringing the position to 5,774 shares worth $699K. The position accounts for 0.62% of the portfolio, ranked #37.

Eagle Bay Advisors first reported a position in MRK in Q2 2021 and has held it in 20 quarters since. The position peaked at $948K in Q2 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Eagle Bay Advisors held 5,774 shares of Merck worth $699K as of Q1 2026.
  • Eagle Bay Advisors bought 109 Merck shares in Q1 2026, an estimated $12.6K.
  • Merck made up 0.62% of Eagle Bay Advisors's portfolio in Q1 2026, its #37 holding.
  • Eagle Bay Advisors first reported a position in Merck in Q2 2021 and has held it in 20 quarters since.
  • Eagle Bay Advisors's Merck position peaked at $948K in Q2 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Eagle Bay Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.